Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study.
Long-term follow-up data after autologous HSCT in patients with systemic sclerosis is provided allowing robust assessment of response rate, late complications, and sustained treatment benefit, and might serve as an important comparator for all upcoming, cellular treatment options.